Tools for targeted manipulation of the mouse genome

Physiological Genomics

Volumn 11, Issue , 2003, Pages 133-164

  Van der Weyden, Louise ^a   Adams, David J ^a   Bradley, Allan ^a,b  

^a WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^b WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

Embryonic stem cell; Gene targeting; Gene trap; Homologous recombination; Mouse genome project; Mutagenesis

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; DEVELOPMENTAL GENETICS; EXPERIMENTAL MOUSE; GENE FUNCTION; GENE SEQUENCE; GENE TARGETING; GENETIC DISORDER; GENOME; HOMOLOGOUS RECOMBINATION; MOUSE; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; STEM CELL; ANIMAL; BIOSYNTHESIS; CHROMOSOME ABERRATION; GENETIC RECOMBINATION; GENETICS; METHODOLOGY; MOUSE MUTANT; TRANSACTIVATION;

ANIMALIA; RODENTIA;

CRE RECOMBINASE; INTEGRASE; VIRUS PROTEIN;

ANIMALS; CHROMOSOME ABERRATIONS; GENE TARGETING; GENOME; INTEGRASES; MICE; MICE, KNOCKOUT; MICE, MUTANT STRAINS; MODELS, ANIMAL; MUTAGENESIS; RECOMBINATION, GENETIC; TRANS-ACTIVATION (GENETICS); VIRAL PROTEINS;

EID: 0037015889     PISSN: 15312267     EISSN: None     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00074.2002     Document Type: Review

References (290)

1. Adams DJ and van der Weyden L. Are we creating problems? Negative effects of Cre recombinase. Genesis 29: 115, 2001.
2. Akagi K, Sandig V, Vooijs M, Van der Valk M, Giovannini M, Strauss M, and Berns A. Cre-mediated somatic site-specific recombination in mice. Nucleic Acids Res 25: 1766-1773, 1997.
3. Allen JD and Berns A. Complementation tagging of cooperating oncogenes in knockout mice. Semin Cancer Biol 7: 299-306, 1996.
4. Angrand PO, Daigle N, van der Hoeven F, Scholer HR, and Stewart AF. Simplified generation of targeting constructs using ET recombination. Nucleic Acids Res 27: e16, 1999.
5. Anton M and Graham FL. Site-specific recombination mediated by an adenovirus vector expressing the Cre recombinase protein: a molecular switch for control of gene expression. J Virol 69: 4600-4606, 1995.
6. Arama E, Dickman D, Kimchie Z, Shearn A, and Lev Z. Mutations in the beta-propeller domain of the Drosophila brain tumor (brat) protein induce neoplasm in the larval brain. Oncogene 19: 3706-3716, 2000.
7. Askew GR, Doetschman T, and Lingrel JB. Site-directed point mutations in embryonic stem cells: a gene-targeting tagand-exchange strategy. Mol Cell Biol 13: 4115-4124, 1993.
8. Araki K, Araki M, Miyazaki J, and Vassalli P. Site-specific recombination of a transgene in fertilized eggs by transient expression of Cre recombinase. Proc Natl Acad Sci USA 92: 160-164, 1995.
9. Araki K, Imaizumi T, Sekimoto T, Yoshinobu K, Yoshimuta J, Akizuki M, Miura K, Araki M, Yamamura K. Exchangeable gene trap using the Cre/mutated lox system. Cell Mol Biol 45, 737-750, 1999.
10. Aratani Y, Koyama H, Nyui S, Suzuki K, Kura F, and Maeda N. Severe impairment in early host defense against Candida albicans in mice deficient in myeloperoxidase. Infect Immun 67: 1828-1836, 1999.
11. Avner P, Bruls T, Poras I, Eley L, Gas S, Ruiz P, Wiles MV, Sousa-Nunes R, Kettleborough R, Rana A, Morissette J, Bentley L, Goldsworthy M, Haynes A, Herbert E, Southam L, Lehrach H, Weissenbach J, Manenti G, Rodriguez-Tome P, Beddington R, Dunwoodie S, and Cox RD. A radiation hybrid transcript map of the mouse genome. Nat Genet 29: 194-200, 2001.
12. Baker RK, Haendel MA, Swanson BJ, Shambaugh JC, Micales BK, and Lyons GE. In vitro preselection of genetrapped embryonic stem cell clones for characterizing novel developmentally regulated genes in the mouse. Dev Biol 185: 201-214, 1997.
13. Balling R. ENU mutagenesis: analyzing gene function in mice. Annu Rev Genom Hum Genet 2: 463-492, 2001.
14. Baron U, Freundlieb S, Gossen M, and Bujard H. Coregulation of two gene activities by tetracycline via a bidirectional promoter. Nucleic Acids Res 23: 3605-3606, 1995.
15. Baron U, Schnappinger D, Helbl V, Gossen M, Hillen W, and Bujard H. Generation of conditional mutants in higher eukaryotes by switching between the expression of two genes. Proc Natl Acad Sci USA 96: 1013-1018, 1999.
16. Baron U and Bujard H. Tet repressor-based system for regulated gene expression in eukaryotic cells: principles and advances. Methods Enzymol 327: 401-421, 2000.
17. Battey J, Jordan E, Cox D, and Dove W. An action plan for mouse genomics. Nat Genet 21: 73-75, 1999.
18. Batzoglou S, Jaffe DB, Stanley K, Butler J, Gnerre S, Mauceli E, Berger B, Mesirov JP, and Lander ES. ARACHNE: a whole-genome shotgun assembler. Genome Res 12: 177-189, 2002.
19. Bedell MA, Largaespada DA, Jenkins NA, and Copeland NG. Mouse models of human disease. II. Recent progress and future directions. Genes Dev 11: 11-43, 1997.
20. Behringer R and Magnuson T (Editors). Tissue specific expression of Cre recombinase in mice (Special Issue). In: Genesis. Wiley-Liss, 2000, vol. 26, issue 2. (http://www3.interscience. wiley.com/cgi-bin/issuetoc?Type=DD& ID=70001850)
21. Behringer R and Magnuson T (Editors). Conditional alleles in mice (Special Issue). In: Genesis. Wiley-Liss, 2002, vol. 32, issue 2. (http://www3.interscience.wiley.com/cgi-bin/issuetoc?ID= 90511963)
22. Bellen HJ, O'Kane CJ, Wilson C, Grossniklaus U, Pearson RK, and Gehring WJ. P-element-mediated enhancer detection: a versatile method to study development in Drosophila. Genes Dev 3: 1288-1300, 1989.
23. Berkovich I and Efrat S. Inducible and reversible β-cell autoimmunity and hyperplasia in transgenic mice expressing a conditional oncogene. Diabetes 50: 2260-2267, 2001.
24. Beumer KJ, Pimpinelli S, and Golic KG. Induced chromosomal exchange directs the segregation of recombinant chromatids in mitosis of Drosophila. Genetics 150: 173-188, 1998.
25. Bjorklund A, Kirik D, Rosenblad C, Georgievska B, Lundberg C, and Mandel RJ. Towards a neuroprotective gene therapy for Parkinson's disease: use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model. Brain Res 886: 82-98, 2000.
26. Bode VC. Ethylnitrosourea mutagenesis and the isolation of mutant alleles for specific genes located in the T region of mouse chromosome 17. Genetics 108: 457-470, 1984.
27. Bollag RJ and Liskay RM. Direct-repeat analysis of chromatid interactions during intrachromosomal recombination in mouse cells. Mol Cell Biol 11: 4839-4845, 1991.
28. Bonaldo P, Chowdhury K, Stoykova A, Torres M, and Gruss P. Efficient gene trap screening for novel developmental genes using IRES beta geo vector and in vitro preselection. Exp Cell Res 244: 125-136, 1998.
29. Bradley A, Zheng B, and Liu P. Thirteen years of manipulating the mouse genome: a personal history. Int J Dev Biol 42: 943-50, 1998.
30. Breitman ML, Clapoff S, Rossant J, Tsui LC, Glode LM, Maxwell IH, and Bernstein A. Genetic ablation: targeted expression of a toxin gene causes microphthalmia in transgenic mice. Science 238: 1563-1565, 1987.
31. Brocard J, Warot X, Wendling O, Messaddeq N, Vonesch JL, Chambon P, and Metzger D. Spatio-temporally controlled site-specific somatic mutagenesis in the mouse. Proc Natl Acad Sci USA 94: 14559-14563, 1997.
32. Buchholz F, Ringrose L, Angrand PO, Rossi F, and Stewart AF. Different thermostabilities of FLP and Cre recombinases: implications for applied site-specific recombination. Nucleic Acids Res 24: 4256-4262, 1996.
33. Buchholz F, Angrand PO, and Stewart AF. Improved properties of FLP recombinase evolved by cycling mutagenesis. Nat Biotechnol 16: 657-662, 1998.
34. Buchholz F, Refaeli Y, Trumpp A, and Bishop JM. Inducible chromosomal translocation of AML1 and ETO genes through Cre/loxP-mediated recombination in the mouse. EMBO Rep 1: 133-139, 2000.
35. Cai WW, Chow CW, Damani S, Gregory SG, Marra M, and Bradley A. An SSLP marker-anchored BAC framework map of the mouse genome. Nat Genet 29: 133-134, 2001.
36. Capecchi MR. Altering the genome by homologous recombination. Science 244: 1288-1292, 1989.
37. Cattanach BM, Burtenshaw MD, Rasberry C, and Evans EP. Large deletions and other gross forms of chromosome imbalance compatible with viability and fertility in the mouse. Nat Genet 3: 56-61, 1993.
38. Cearley JA and Detloff PJ. Efficient repetitive alteration of the mouse Huntington's disease gene by management of background in the tag and exchange gene targeting strategy. Transgenic Res 10: 479-488, 2001.
39. Cecconi F and Meyer BI. Gene trap: a way to identify novel genes and unravel their biological function. FEBS Lett 480: 63-71, 2000.
40. Cheah SS and Behringer RR. Contemporary gene targeting strategies for the novice. Mol Biotechnol 19: 297-304, 2001.
41. Chen Y, Yee D, Dains K, Chatterjee A, Cavalcoli J, Schneider E, Om J, Woychik RP, and Magnuson T. Genotype-based screen for ENU-induced mutations in mouse embryonic stem cells. Nat Genet 24: 314-317, 2000.
42. Chen CM, and Behringer RR CREating breakthroughs. Nat Biotechnol 19: 921-922, 2001.
43. Chowdhury K, Bonaldo P, Torres M, Stoykova A, and Gruss P. Evidence for the stochastic integration of gene trap vectors into the mouse germline. Nucleic Acids Res 25: 1531-1536, 1997.
44. Collins EC, Pannell R, Simpson EM, Forster A, and Rabbitts TH. Inter-chromosomal recombination of Mll and Af9 genes mediated by cre-loxP in mouse development. EMBO Rep 1: 127-132, 2000.
45. Copeland NG, Jenkins NA, and Court DL. Recombineering: a powerful new tool for mouse functional genomics. Nat Rev Genet 2: 769-779, 2001.
46. Corral J, Lavenir I, Impey H, Warren AJ, Forster A, Larson TA, Bell S, McKenzie AN, King G, and Rabbitts TH. An Mll-AF9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice: a method to create fusion oncogenes. Cell 85: 853-861, 1996.
47. Cox RD, Hugill A, Shedlovsky A, Noveroske JK, Best S, Justice MJ, Lehrach H, and Dove WF. Contrasting effects of ENU induced embryonic lethal mutations of the quaking gene. Genomics 57: 333-341, 1999.
48. Davis AP and Justice MJ. Mouse alleles: if you've seen one, you haven't seen them all. Trends Genet 14: 438-441, 1998.
49. Davisson MT, Schmidt C, and Akeson EC. Segmental trisomy of murine chromosome 16: a new model system for studying Down syndrome. Prog Clin Biol Res 360:263-280, 1990.
50. de Alboran IM, O'Hagan RC, Gartner F, Malynn B, Davidson L, Rickert R, Rajewsky K, DePinho RA, and Alt FW. Analysis of C-MYC function in normal cells via conditional gene-targeted mutation. Immunity 14: 45-55, 2001.
51. Dickinson P, Kimber WL, Kilanowski FM, Webb S, Stevenson BJ, Porteous DJ, and Dorin JR. Enhancing the efficiency of introducing precise mutations into the mouse genome by hit and run gene targeting. Transgenic Res 9: 55-66, 2000.
52. Dietrich WF, Lander ES, Smith JS, Moser AR, Gould KA, Luongo C, Borenstein N, and Dove W. Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Cell 75: 631-639, 1993.
53. Dietrich WF, Miller J, Steen R, Merchant MA, Damron-Boles D, Husain Z, Dredge R, Daly MJ, Ingalls KA, O'Connor TJ, Evans CA, DeAngelis MM, Levinson DM, Kruglyak L, Goodman N, Copeland NG, Jenkins NA, Hawkins TL, Stein L, Page DC, and Lander ES. A comprehensive genetic map of the mouse genome. Nature 380: 149-152, 1996.
54. Doetschman T, Gregg RG, Maeda N, Hooper ML, Melton DW, Thompson S, and Smithies O. Targetted correction of a mutant HPRT gene in mouse embryonic stem cells. Nature 330: 576-578, 1987.
55. Dymecki SM. Site-specific recombination in cells and mice. In: Gene Targeting: a Practical Approach (2nd ed.), edited by Joyner AL. New York: Oxford University Press, 2000, chapt. 2, p. 37-100.
56. Eppig JT and Strivens M. Finding a mouse: the International Mouse Strain Resource (IMSR). Trends Genet 15: 81-82, 1999.
57. Evans MJ. Gene trapping: a preface. Dev Dyn 212: 167-169, 1998.
58. Farley FW, Soriano P, Steffen LS, and Dymecki SM. Widespread recombinase expression using FLPeR (flipper) mice. Genesis 28: 106-110, 2000.
59. Favor J and Neuhäuser-Klaus A. Saturation mutagenesis for dominant eye morphological defects in the mouse Mus musculus. Mamm Genome 11:520-525, 2000.
60. Favor J and Neuhauser-Klaus A. Genetic mosaicism in the house mouse. Annu Rev Genet 28: 27-47, 1994.
61. Feil R, Brocard J, Mascrez B, LeMeur M, Metzger D, and Chambon P. Ligand-activated site-specific recombination in mice. Proc Natl Acad Sci USA 93: 10887-10890, 1996.
62. Feng YQ, Seibler J, Alami R, Eisen A, Westerman KA, Leboulch P, Fiering S, and Bouhassira EE. Site-specific chromosomal integration in mammalian cells: highly efficient CRE recombinase-mediated cassette exchange. J Mol Biol 292: 779-785, 1999.
63. Flaherty L, Messer A, Russell LB, and Rinchik EM. Chlorambucil-induced mutations in mice recovered in homozygotes. Proc Natl Acad Sci USA 89: 2859-2863, 1992.
64. Flaherty L and Herron B. The new kid on the block: a whole genome mouse radiation hybrid panel. Mamm Genome 9: 417-418, 1998.
65. Forrester LM, Nagy A, Sam M, Watt A, Stevenson L, Bernstein A, Joyner AL, and Wurst W. Induction gene trapping in ES cells: identification of developmentally regulated genes that respond to retinoic acid. Proc Natl Acad Sci USA 93: 1677-1682, 1996.
66. Friedrich G and Soriano P. Promoter traps in embryonic stem cells: a genetic screen to identify and mutate developmental genes in mice. Genes Dev 5: 1513-1523, 1991.
67. Fuhrmann-Benzakein E, Garcia-Gabay I, Pepper MS, Vassalli JD, and Herrera PL. Inducible and irreversible control of gene expression using a single transgene. Nucleic Acids Res 28: E99, 2000.
68. Gajovic S, Chowdhury K, and Gruss P. Genes expressed after retinoic acid-mediated differentiation of embryoid bodies are likely to be expressed during embryo development. Exp Cell Res 242: 138-143, 1998.
69. Geng Y, Whoriskey W, Park MY, Bronson RT, Medema RH, Li T, Weinberg RA, and Sicinski P. Rescue of cyclin Dl deficiency by knockin cyclin E. Cell 97: 767-777, 1999.
70. German J. Bloom syndrome: a Mendelian prototype of somatic mutational disease. Medicine (Baltimore) 72: 393-406, 1993.
71. Gondo Y, Nakamura K, Nakao K, Sasaoka T, Ito K, Kimura M, and Katsuki M. Gene replacement of the p53 gene with the lacZ gene in mouse embryonic stem cells and mice by using two steps of homologous recombination. Biochem Biophys Res Commun 202: 830-837, 1994.
72. Gossen M and Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 89: 5547-5551, 1992.
73. Gossen M, Freundlieb S, Bender G, Muller G, Hillen W, and Bujard H. Transcriptional activation by tetracyclines in mammalian cells. Science 268: 1766-1769, 1995.
74. Gossler A, Joyner AL, Rossant J, and Skarnes WC. Mouse embryonic stem cells and reporter constructs to detect developmentally regulated genes. Science 244: 463-465, 1989.
75. Gschwind M and Huber G. Introduction of hereditary disease-associated mutations into the beta-amyloid precursor protein gene of mouse embryonic stem cells: a comparison of homologous recombination methods. Mol Cell Biol 18: 4651-4658, 1998.
76. Gu H, Marth JD, Orban PC, Mossmann H, and Rajewsky K. Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting. Science 265: 103-106, 1994.
77. Hamilton CM, Aldea M, Washburn BK, Babitzke P, and Kushner SR. New method for generating deletions and gene replacements in Escherichia coli. J Bacteriol 171: 4617-4622, 1989.
78. Hanks M, Wurst W, Anson-Cartwright L, Auerbach AB, and Joyner AL. Rescue of the En-1 mutant phenotype by replacement of En-1 with En-2. Science 269: 679-682, 1995.
79. Harbers K, Kuehn M, Delius H, and Jaenisch R. Insertion of retrovirus into the first intron of 1(I) collagen gene leads to embryonic lethal mutation in mice. Proc Natl Acad Sci USA 81: 1504-1508, 1984.
80. Hardouin N and Nagy A. Gene-trap-based target site for Cre-mediated transgenic insertion. Genesis 26: 245-252, 2000.
81. Hashimoto-Gotoh T and Sekiguchi M. Mutations of temperature sensitivity in R plasmid pSC101. J Bacteriol 131: 405-412, 1977.
82. Hasty P, Ramirez-Solis R, Krumlauf R, and Bradley A. Introduction of a subtle mutation into the Hox-2.6 locus in embryonic stem cells. Nature 350: 243-246, 1991.
83. Hasty P, Rivera-Perez J, Chang C, and Bradley A. Target frequency and integration pattern for insertion and replacement vectors in embryonic stem cells. Mol Cell Biol 11: 4509-4517, 1991.
84. Hasty P, Abuin A, and Bradley A. Gene targeting, principles, and practice in mammalian cells. In: Gene Targeting: A Practical Approach (2nd ed.), edited by Joyner AL. New York: Oxford University Press, 2000, chapt. 1, p. 1-35.
85. Hicks GG, Shi EG, Li XM, Li CH, Pawlak M, and Ruley HE. Functional genomics in mice by tagged sequence mutagenesis. Nat Genet 16: 338-344, 1997.
86. Hidaka M, Caruana G, Stanford WL, Sam M, Correll PH, and Bernstein A. Gene trapping of two novel genes, Hzf and Hhl, expressed in hematopoietic cells. Mech Dev 90: 3-15, 2000.
87. Holland EC, Hively WP, DePinho RA, and Varmus HE. A constitutively active epidermal growth factor receptor cooperates with disruption of G1 cell-cycle arrest pathways to induce glioma-like lesions in mice. Genes Dev 12: 3675-3685, 1998.
88. Hrabe de Angelis M and Balling R. Large scale ENU screens in the mouse: genetics meets genomics. Mutat Res 400: 25-32, 1998.
89. Hrabe de Angelis MH, Flaswinkel H, Fuchs H, Rathkolb B, Soewarto D, Marschall S, Heffner S, Pargent W, Wuensch K, Jung M, Reis A, Richter T, Alessandrini F, Jakob T, Fuchs E, Kolb H, Kremmer E, Schaeble K, Rollinski B, Roscher A, Peters C, Meitinger T, Strom T, Steckler T, Holsboer F, Klopstock T, Gekeler F, Schindewolf C, Jung T, Avraham K, Behrendt H, Ring J, Zimmer A, Schughart K, Pfeffer K, Wolf E, and Balling R. Genomewide, large-scale production of mutant mice by ENU mutagenesis. Nat Genet 25: 444-447, 2000.
90. Hudson TJ, Church DM, Greenaway S, Nguyen H, Cook A, Steen RG, Van Etten WJ, Castle AB, Strivens MA, Trickett P, Heuston C, Davison C, Southwell A, Hardisty R, Varela-Carver A, Haynes AR, Rodriguez-Tome P, Doi H, Ko MS, Pontius J, Schriml L, Wagner L, Maglott D, Brown SD, Lander ES, Schuler G, and Denny P. A radiation hybrid map of mouse genes. Nat Genet 29: 201-205, 2001.
91. Hug BA, Wesselschmidt RL, Fiering S, Bender MA, Epner E, Groudine M, and Ley TJ. Analysis of mice containing a targeted deletion of beta-globin locus control region 5′ hypersensitive site 3. Mol Cell Biol 16: 2906-2912, 1996.
92. Indra AK, Warot X, Brocard J, Bornert JM, Xiao JH, Chambon P, and Metzger D. Temporally-controlled site-specific mutagenesis in the basal layer of the epidermis: comparison of the recombinase activity of the tamoxifen-inducible Cre-ER(T) and Cre-ER(T2) recombinases. Nucleic Acids Res 27: 4324-4327, 1999.
93. Ivics Z, Hackett PB, Plasterk RH, and Izsvak Z. Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells. Cell 91: 501-510, 1997.
94. Izsvak Z, Ivics Z, and Plasterk RH. Sleeping Beauty, a wide host-range transposon vector for genetic transformation in vertebrates. J Mol Biol 302: 93-102, 2000.
95. Jenkins NA, Copeland NG, Taylor BA, and Lee BK. Dilute (d) coat colour mutation of DBA/2J mice is associated with the site of integration of an ecotropic MuLV genome. Nature 293: 370-374, 1981.
96. Jo D, Nashabi A, Doxsee C, Lin Q, Unutmaz D, Chen J, and Ruley HE. Epigenetic regulation of gene structure and function with a cell-permeable Cre recombinase. Nat Biotechnol 19: 929-933, 2001.
97. Johnson L, Mercer K, Greenbaum D, Bronson RT, Crowley D, Tuveson DA, and Jacks T. Somatic activation of the K-ras oncogene causes early onset lung cancer in mice. Nature 410: 1111-1116, 2001.
98. Jonkers J, Meuwissen R, van der Gulden H, Peterse H, van der Valk M, and Berns A. Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer. Nat Genet 29: 418-425, 2001.
99. Jonkers J and Berns A. Conditional mouse models of sporadic cancer. Nat Rev Cancer 2: 251-265, 2002.
100. Joshi SK, Hashimoto K, and Koni PA. Induced DNA recombination by Cre recombinase protein transduction. Genesis 33: 48-54, 2002.
101. Joza N, Susin SA, Daugas E, Stanford WL, Cho SK, Li CY, Sasaki T, Elia AJ, Cheng HY, Ravagnan L, Ferri KF, Zamzami N, Wakeham A, Hakem R, Yoshida H, Kong YY, Mak TW, Zuniga-Pflucker JC, Kroemer G, and Penninger JM. Essential role of the mitochondrial apoptosis inducing factor in programmed cell death. Nature 410: 549-554, 2001.
102. Justice MJ and Bode VC. ENU-induced allele of brachyury (Tktl) exhibits a developmental lethal phenotype similar to the original brachyury (T) mutation. J Exp Zool 254: 286-295, 1990.
103. Justice MJ and Bode VC. Induction of new mutations in a mouse t-haplotype using ethylnitrosourea mutagenesis. Genet Res 47: 187-192, 1986.
104. Justice MJ and Bode VC. Three ENU-induced alleles of the murine quaking locusare recessive embryonic lethal mutations. Genet Res 51: 95-102, 1988.
105. Justice MJ, Zheng B, Woychik RP, and Bradley A. Using targeted large deletions and high-efficiency N-ethyl-N-nitrosourea mutagenesis for functional analyses of the mammalian genome. Methods 13: 423-436, 1997.
106. Justice MJ, Noveroske JK, Weber JS, Zheng B, and Bradley A. Mouse ENU mutagenesis. Hum Mol Genet 8: 1955-1963, 1999.
107. Justice MJ. Capitalizing on large-scale mouse mutagenesis screens. Nat Rev Genet 1: 109-115, 2000.
108. Kaartinen V and Nagy A. Removal of the floxed neo gene from a conditional knockout allele by the adenoviral Cre recombinase in vivo. Genesis 31: 126-129, 2001.
109. Kasarskis A, Manova K, and Anderson KV. A phenotype-based screen for embryonic lethal mutations in the mouse. Proc Natl Acad Sci USA 95: 7485-7490, 1998.
110. Kaspar BK, Vissel B, Bengoechea T, Crone S, Randolph-Moore L, Muller R, Brandon EP, Schaffer D, Verma IM, Lee KF, Heinemann SF, and Gage FH. Adeno-associated virus effectively mediates conditional gene modification in the brain. Proc Natl Acad Sci USA 99: 2320-2325, 2002.
111. Kawai J, Shinagawa A, Shibata K, Yoshino M, Itoh M, Ishii Y, Arakawa T, Hara A, Fukunishi Y, Konno H, Adachi J, Fukuda S, Aizawa K, Izawa M, Nishi K, Kiyosawa H, Kondo S, Yamanaka I, Saito T, Okazaki Y, Gojobori T, Bono H, Kasukawa T, Saito R, Kadota K, Matsuda HA, Ashburner M, Batalov S, Casavant T, Fleischmann W, Gaasterland T, Gissi C, King B, Kochiwa H, Kuehl P, Lewis S, Matsuo Y, Nikaido I, Pesole G, Quackenbush J, Schriml LM, Staubli F, Suzuki R, Tomita M, Wagner L, Washio T, Sakai K, Okido T, Furuno M, Aono H, Baldarelli R, Barsh G, Blake J, Boffelli D, Bojunga N, Carninci P, de Bonaldo MF, Brownstein MJ, Bult C, Fletcher C, Fujita M, Gariboldi M, Gustincich S, Hill D, Hofmann M, Hume DA, Kamiya M, Lee NH, Lyons P, Marchionni L, Mashima J, Mazzarelli J, Mombaerts P, Nordone P, Ring B, Ringwald M, Rodriguez I, Sakamoto N, Sasaki H, Sato K, Schonbach C, Seya T, Shibata Y, Storch KF, Suzuki H, Toyo-oka K, Wang KH, Weitz C, Whittaker C, Wilming L, Wynshaw-Boris A, Yoshida K, Hasegawa Y, Kawaji H, Kohtsuki S, and Hayashizaki Y. Functional annotation of a full-length mouse cDNA collection. Nature 409: 685-690, 2001.
112. Kim DG, Kang HM, Jang SK, and Shin HS. Construction of a bifunctional mRNA in the mouse by using the internal ribosomal entry site of the encephalomyocarditis virus. Mol Cell Biol 12: 3636-3643, 1992.
113. King W, Patel MD, Lobel LI, Goff SP, and Nguyen-Huu MC. Insertion mutagenesis of embryonal carcinoma cells by retroviruses. Science 228: 554-558, 1985.
114. Komada M, McLean DJ, Griswold MD, Russell LD, and Soriano P. E-MAP-115, encoding a microtubule-associated protein, is a retinoic acid-inducible gene required for spermatogenesis. Genes Dev 14: 1332-1342, 2000.
115. Kobayashi T, Kida Y, Kaneko T, Pastan I, and Kobayashi K. Efficient ablation by immunotoxin-mediated cell targeting of the cell types that express human interleukin-2 receptor depending on the internal ribosome entry site. J Gene Med 3: 505-510, 2001.
116. Kucera GT, Bortner DM, and Rosenberg MP. Overexpression of an Agouti cDNA in the skin of transgenic mice recapitulates dominant coat color phenotypes of spontaneous mutants. Dev Biol 173: 162-173, 1996.
117. Kuehn MR, Bradley A, Robertson EJ, and Evans MJ. A potential animal model for Lesch-Nyhan syndrome through introduction of HPRT mutations into mice. Nature 326: 295-298, 1987.
118. Kushi A, Edamura K, Noguchi M, Akiyama K, Nishi Y, and Sasai H. Generation of mutant mice with large chromosomal deletion by use of irradiated ES cells: analysis of large deletion around hprt locus of ES cell. Mamm Genome 9: 269-273, 1998.
119. Kushner SR, Nagaishi H, and Clark AJ. Isolation of exonuclease VIII: the enzyme associated with sbcA indirect suppressor. Proc Natl Acad Sci USA 71: 3593-3597, 1974.
120. Lampe DJ, Churchill ME, Robertson HM. A purified mariner transposase is sufficient to mediate transposition in vitro. EMBO J 15: 5470-5479, 1996.
121. Lallemand Y, Luria V, Haffner-Krausz R, and Lonai P. Maternally expressed PGK-Cre transgene as a tool for early and uniform activation of the Cre site-specific recombinase. Transgenic Res 7: 105-112, 1998.
122. Lavon I, Goldberg I, Amit S, Landsman L, Jung S, Tsuberi BZ, Barshack I, Kopolovic J, Galun E, Bujard H, Ben-Neriah Y. High susceptibility to bacterial infection, but no liver dysfunction, in mice compromised for hepatocyte NF-B activation. Nat Med 6: 573-577, 2000.
123. Lee EC, Yu D, Martinez de Velasco J, Tessarollo L, Swing DA, Court DL, Jenkins NA, and Copeland NG. A highly efficient Escherichia coli-based chromosome engineering system adapted for recombinogenic targeting and subcloning of BAC DNA. Genomics 73: 56-65, 2001.
124. Leighton PA, Mitchell KJ, Goodrich LV, Lu X, Pinson K, Scherz P, Skarnes WC, and Tessier-Lavigne M. Defining brain wiring patterns and mechanisms through gene trapping in mice. Nature 410: 174-179, 2001.
125. LePage DF, Church DM, Millie E, Hassold TJ, and Conlon RA. Rapid generation of nested chromosomal deletions on mouse chromosome 2. Proc Natl Acad Sci USA 97: 10471-10476, 2000.
126. Lewandoski M. Conditional control of gene expression in the mouse. Nat Rev Genet 2: 743-755, 2001.
127. Lewis SE, Barnett LB, Akeson EC, and Davisson MT. A new dominant neurological mutant induced in the mouse by ethylene oxide. Mutat Res 229: 135-139, 1990.
128. Li ZW, Stark G, Gotz J, Rulicke T, Gschwind M, Huber G, Muller U, and Weissmann C. Generation of mice with a 200-kb amyloid precursor protein gene deletion by Cre recombinase-mediated site-specific recombination in embryonic stem cells. Proc Natl Acad Sci USA 93: 6158-6162, 1996.
129. Li M, Indra AK, Warot X, Brocard J, Messaddeq N, Kato S, Metzger D, and Chambon P. Skin abnormalities generated by temporally controlled RXRα mutations in mouse epidermis. Nature 407: 633-636, 2000.
130. Lin FL, Sperle K, and Sternberg N. Recombination in mouse L cells between DNA introduced into cells and homologous chromosomal sequences. Proc Natl Acad Sci USA 82: 1391-1395, 1985.
131. Lindblad-Toh K, Winchester E, Daly MJ, Wang DG, Hirschhorn JN, Laviolette JP, Ardlie K, Reich DE, Robinson E, Sklar P, Shah N, Thomas D, Fan JB, Gingeras T, Warrington J, Patil N, Hudson TJ, and Lander ES. Largescale discovery and genotyping of single-nucleotide polymorphisms in the mouse. Nat Genet 24: 381-386, 2000.
132. Lindblad-Toh K, Lander ES, McPherson JD, Waterston RH, Rodgers J, and Birney E. Progress in sequencing the mouse genome. Genesis 31: 137-141, 2001.
133. Lindsay EA, Botta A, Jurecic V, Carattini-Rivera S, Cheah YC, Rosenblatt HM, Bradley A, and Baldini A. Congenital heart disease in mice deficient for the DiGeorge syndrome region. Nature 401: 379-383, 1999.
134. Lindsay EA, Vitelli F, Su H, Morishima M, Huynh T, Pramparo T, Jurecic V, Ogunrinu G, Sutherland HF, Scambler PJ, Bradley A, and Baldini A. Tbx1 haploinsufficiency in the DiGeorge syndrome region causes aortic arch defects in mice. Nature 410: 97-101, 2001.
135. Liu P, Zhang H, McLellan A, Vogel H, and Bradley A. Embryonic lethality and tumorigenesis caused by segmental aneuploidy on mouse chromosome 11. Genetics 150: 1155-1168, 1998.
136. Liu Q, Li MZ, Leibham D, Cortez D, and Elledge SJ. The univector plasmid-fusion system, a method for rapid construction of recombinant DNA without restriction enzymes. Curr Biol 8: 1300-1309, 1998.
137. Liu P, Jenkins NA, and Copeland NG. Efficient Cre-loxP-induced mitotic recombination in mouse embryonic stem cells. Nat Genet 30: 66-72, 2002.
138. Lloyd RG. The segregation of the SbcA and Rac phenotypes in an Escherichia coli recB mutant. Mol Gen Genet 134: 249-259, 1974.
139. Lo WD, Qu G, Sferra TJ, Clark R, Chen R, and Johnson PR. Adeno-associated virus-mediated gene transfer to the brain: duration and modulation of expression. Hum Gene Ther 10: 201-213, 1999.
140. Loonstra A, Vooijs M, Beverloo HB, Allak BA, van Drunen E, Kanaar R, Berns A, and Jonkers J. Growth inhibition and DNA damage induced by Cre recombinase in mammalian cells. Proc Natl Acad Sci USA 98: 9209-9214, 2001.
141. Look AT. Oncogenic transcription factors in the human acute leukemias. Science 278: 1059-1064, 1997.
142. Luo G, Ivics Z, Izsvak Z, and Bradley A. Chromosomal transposition of a Tc1/mariner-like element in mouse embryonic stem cells. Proc Natl Acad Sci USA 95: 10769-10773, 1998.
143. Luo G, Santoro IM, McDaniel LD, Nishijima I, Mills M, Youssoufian H, Vogel H, Schultz RA, and Bradley A. Cancer predisposition caused by elevated mitotic recombination in Bloom mice. Nat Genet 26: 424-429, 2000.
144. Lyon MF and Meredith R. Autosomal translocations causing male sterility and viable aneuploidy in the mouse. Cytogenetics 5: 335-354, 1966.
145. Mainguy G, Montesinos ML, Lesaffre B, Zevnik B, Karasawa M, Kothary R, Wurst W, Prochiantz A, and Volovitch M. An induction gene trap for identifying a homeoprotein-regulated locus. Nat Biotechnol 18: 746-749, 2000.
146. Mansouri A, Pla P, Larue L, and Gruss P. Pax3 acts cell autonomously in the neural tube and somites by controlling cell surface properties. Development 128: 1995-2005, 2001.
147. Marra M, Hillier L, Kucaba T, Allen M, Barstead R, Beck C, Blistain A, Bonaldo M, Bowers Y, Bowles L, Cardenas M, Chamberlain A, Chappell J, Clifton S, Favello A, Geisel S, Gibbons M, Harvey N, Hill F, Jackson Y, Kohn S, Lennon G, Mardis E, Martin J, and Waterston R. An encyclopedia of mouse genes. Nat Genet 21: 191-194, 1999.
148. McClive P, Pall G, Newton K, Lee M, Mullins J, and Forrester L. Gene trap integrations expressed in the developing heart: insertion site affects splicing of the PT1-ATG vector. Dev Dyn 212: 267-276, 1998.
149. McCown TJ, Xiao X, Li J, Breese GR, and Samulski RJ. Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector. Brain Res 713: 99-107, 196.
150. Medico E, Gambarotta G, Gentile A, Comoglio PM, and Soriano P. A gene trap vector system for identifying transcriptionally responsive genes. Nat Biotechnol 19: 579-582, 2001.
151. Medina-Martinez O, Bradley A, and Ramirez-Solis R. A large targeted deletion of Hoxb1-Hoxb9 produces a series of single-segment anterior homeotic transformations. Dev Biol 222: 71-83, 2000.
152. Mills AA, Zheng B, Wang XJ, Vogel H, Roop DR, and Bradley A. p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 398: 708-713, 1999.
153. Misulovin Z, Yang XW, Yu W, Heintz N, and Meffre E. A rapid method for targeted modification and screening of recombinant bacterial artificial chromosome. J Immunol Methods 257:99-105, 2001.
154. Mitchell KJ, Pinson KI, Kelly OG, Brennan J, Zupicich J, Scherz P, Leighton PA, Goodrich LV, Lu X, Avery BJ, Tate P, Dill K, Pangilinan E, Wakenight P, Tessier-Lavigne M, and Skarnes WC. Functional analysis of secreted and transmembrane proteins critical to mouse development. Nat Genet 28: 241-249, 2001.
155. Mitelman F, Mertens F, and Johansson B. A breakpoint map of recurrent chromosomal rearrangements in human neoplasia. Nat Genet 15, Spec No: 417-474, 1997.
156. Moore RC, Redhead NJ, Selfridge J, Hope J, Manson JC, and Melton DW. Double replacement gene targeting for the production of a series of mouse strains with different prion protein gene alterations. Biotechnology 13: 999-1004, 1995.
157. Mortensen RM, Conner DA, Chao S, Geisterfer-Lowrance AA, and Seidman JG. Production of homozygous mutant ES cells with a single targeting construct. Mol Cell Biol 12: 2391-2395, 1992.
158. Moser AR, Pitot HC, and Dove WF. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 247: 322-324, 1990.
159. Murphy KC. Use of bacteriophage lambda recombination functions to promote gene replacement in Escherichia coli. J Bacteriol 180: 2063-2071, 1998.
160. Muth K, Bruyns R, Thorey IS, and von Melchner H. Disruption of genes regulated during hematopoietic differentiation of mouse embryonic stem cells. Dev Dyn 212: 277-283, 1998.
161. Muyrers JP, Zhang Y, Testa G, and Stewart AF. Rapid modification of bacterial artificial chromosomes by ET-recombination. Nucleic Acids Res 27: 1555-1557, 1999.
162. Muyrers JP, Zhang Y, Benes V, Testa G, Ansorge W, and Stewart AF. Point mutation of bacterial artificial chromosomes by ET recombination. EMBO Rep 1: 239-243, 2000.
163. Muyrers JP, Zhang Y, and Stewart AF. ET-cloning: think recombination first. Genet Eng 22: 77-98, 2000.
164. Muyrers JP, Zhang Y, and Stewart AF. Techniques: Recombinogenic engineering: new options for cloning and manipulating DNA. Trends Biochem Sci 26: 325-331, 2001.
165. Nadeau JH, Balling R, Barsh G, Beier D, Brown SD, Bucan M, Camper S, Carlson G, Copeland N, Eppig J, Fletcher C, Frankel WN, Ganten D, Goldowitz D, Goodnow C, Guenet JL, Hicks G, de Angelis MH, Jackson I, Jacob HJ, Jenkins N, Johnson D, Justice M, Kay S, Kingsley D, Lehrach H, Magnuson T, Meisler M, Poustka A, Rinchik EM, Rossant J, Russell LB, Schimenti J, Shiroishi T, Skarnes WC, Soriano P, Stanford W, Takahashi JS, Wurst W, and Zimmer A. Sequence interpretation. Functional annotation of mouse genome sequences. Science 291: 1251-1255, 2001.
166. Nagy A. Cre recombinase: the universal reagent for genome tailoring. Genesis 26: 99-109, 2000.
167. Narayanan K, Williamson R, Zhang Y, Stewart AF, and Ioannou PA. Efficient and precise engineering of a 200 kb beta-globin human/bacterial artificial chromosome in E. coli DH10B using an inducible homologous recombination system. Gene Ther 6: 442-447, 1999.
168. Narita N, Bielinska M, and Wilson DB. Cardiomyocyte differentiation by GATA-4-deficient embryonic stem cells. Development 122: 3755-3764, 1996.
169. Niwa H, Araki K, Kimura S, Taniguchi S, Wakasugi S, and Yamamura K. An efficient gene-trap method using poly A trap vectors and characterization of gene-trap events. J Biochem (Tokyo) 113: 343-349, 1993.
170. Nolan PM, Peters J, Strivens M, Rogers D, Hagan J, Spurr N, Gray IC, Vizor L, Brooker D, Whitehill E, Washbourne R, Hough T, Greenaway S, Hewitt M, Liu X, McCormack S, Pickford K, Selley R, Wells C, Tymowska-Lalanne Z, Roby P, Glenister P, Thornton C, Thaung C, Stevenson JA, Arkell R, Mburu P, Hardisty R, Kiernan A, Erven A, Steel KP, Voegeling S, Guenet JL, Nickols C, Sadri R, Nasse M, Isaacs A, Davies K, Browne M, Fisher EM, Martin J, Rastan S, Brown SD, and Hunter J. A systemic, genome-wide, phenotype-driven mutagenesis programme for gene function studies in the mouse. Nat Genet 25: 440-443, 2000.
171. Nusbaum C, Slonim DK, Harris KL, Birren BW, Steen RG, Stein LD, Miller J, Dietrich WF, Nahf R, Wang V, Merport O, Castle AB, Husain Z, Farino G, Gray D, Anderson MO, Devine R, Horton LT Jr, Ye W, Wu X, Kouyoumjian V, Zemsteva IS, Wu Y, Collymore AJ, Courtney DF, Tam J, Cadman M, Haynes AR, Heuston C, Marsland T, Southwell A, Trickett P, Strivens MA, Ross MT, Makalowski W, Xu Y, Boguski MS, Carter NP, Denny P, Brown SDM, Hudson TJ, and Lander ES. A YAC-based physical map of the mouse genome. Nat Genet 22: 388-393, 1999.
172. Nusse R and Varmus HE. Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell 31: 99-109, 1982.
173. O'Connor M, Peifer M, and Bender W. Construction of large DNA segments in Escherichia coli. Science 244: 1307-1312, 1989.
174. O'Gorman S, Dagenais NA, Qian M, and Marchuk Y. Protamine-Cre recombinase transgenes efficiently recombine target sequences in the male germ line of mice, but not in embryonic stem cells. Proc Natl Acad Sci USA 94: 14602-14607, 1997.
175. Okuda T, Cai Z, Yang S, Lenny N, Lyu CJ, van Deursen JM, Harada H, and Downing JR. Expression of a knocked-in AML1-ETO leukemia gene inhibits the establishment of normal definitive hematopoiesis and directly generates dysplastic hematopoietic progenitors. Blood 91: 3134-3143, 1998.
176. Olson EN, Arnold HH, Rigby PW, and Wold BJ. Know your neighbors: three phenotypes in null mutants of the myogenic bHLH gene MRF4. Cell 85: 1-4, 1996.
177. Ornitz DM, Moreadith RW, and Leder P. Binary system for regulating transgene expression in mice: targeting int-2 gene expression with yeast GAL4/UAS control elements. Proc Natl Acad Sci USA 88: 698-702, 1991.
178. Osoegawa K, Tateno M, Woon PY, Frengen E, Mammoser AG, Catanese JJ, Hayashizaki Y, and de Jong PJ. Bacterial artificial chromosome libraries for mouse sequencing and functional analysis. Genome Res 10: 116-128, 2000.
179. Overbeek PA, Aguilar-Cordova E, Hanten G, Schaffner DL, Patel P, Lebovitz RM, and Lieberman MW. Coinjection strategy for visual identification of transgenic mice. Transgenic Res 1: 31-37, 1991.
180. Palmiter RD and Brinster RL. Germ-line transformation of mice. Annu Rev Genet 20: 465-499, 1986.
181. 6-alkylguanine. FASEB J 6: 2302-2310, 1992.
182. Peters J, Andrews SJ, Loutit JF, and Clegg JB. A mouse beta-globin mutant that is an exact model of hemoglobin Rainier in man. Genetics 110: 709-721, 1985.
183. Peitz M, Pfannkuche K, Rajewsky K, and Edenhofer F. Ability of the hydrophobic FGF and basic TAT peptides to promote cellular uptake of recombinant Cre recombinase: a tool for efficient genetic engineering of mammalian genomes. Proc Natl Acad Sci USA 99: 4489-4494, 2002.
184. Pelletier J and Sonenberg N. Internal binding of eucaryotic ribosomes on poliovirus RNA: translation in HeLa cell extracts. J Virol 63: 441-444, 1989.
185. Pham CT, MacIvor DM, Hug BA, Heusel JW, and Ley TJ. Long-range disruption of gene expression by a selectable marker cassette. Proc Natl Acad Sci USA 93: 13090-13095, 1996.
186. Pierson TM, Wang Y, DeMayo FJ, Matzuk MM, Tsai SY, and Omalley BW. Regulable expression of inhibin A in wildtype and inhibin null mice. Mol Endocrinol 14: 1075-1085, 2000.
187. Plasterk RH. Methods in Cell Biology. New York: Academic, 1995, p. 59-80.
188. Plasterk RHA. The Tc1/mariner transposon family. Curr Top Microbiol Immunol 204: 125-143, 1996.
189. Pollock JL, Westervelt P, Kurichety AK, Pelicci PG, Grisolano JL, and Ley TJ. A bcr-3 isoform of RARα-PML potentiates the development of PML-RARα-driven acute promyelocytic leukemia. Proc Natl Acad Sci USA 96: 15103-15108, 1999.
190. Popp RA, Bailiff EG, Skow LC, Johnson FM, and Lewis SE. Analysis of a mouse α-globin gene mutation induced by ethylnitrosurea. Genetics 105: 157-67, 1983.
191. Poteete AR, Fenton AC, and Murphy KC. Roles of RuvC and RecG in phage lambda red-mediated recombination. J Bacteriol 181: 5402-5408, 1999.
192. Rabbitts TH. Chromosomal translocations in human cancer. Nature 372: 143-149, 1994.
193. Ramirez-Solis R, Liu P, and Bradley A. Chromosome engineering in mice. Nature 378: 720-724, 1995.
194. Reddy S, DeGregori JV, von Melchner H, and Ruley HE. Retrovirus promoter-trap vector to induce lacZ gene fusions in mammalian cells. J Virol 19: 17-23, 1991.
195. Reeves RH, Irving NG, Moran TH, Wohn A, Kitt C, Sisodia SS, Schmidt C, Bronson RT, and Davisson MT. A mouse model for Down syndrome exhibits learning and behaviour deficits. Nat Genet 11: 177-184, 1995.
196. Rinchik EM, Carpenter DA, and Selby PB. A strategy for fine-structure functional analysis of a 6- to 11-cM region of mouse chromosome 7 by high-efficiency mutagenesis. Proc Natl Acad Sci USA 87: 896-900, 1990.
197. Rinchik EM. Chemical mutagenesis and fine-structure functional analysis of the mouse genome. Trends Genet 7: 15-21, 1991.
198. Rinchik EM, Carpenter DA, and Handel MA. Pleiotropy in microdeletion syndromes: neurologic and spermatogenic abnormalities in mice homozygous for the p6H deletion are likely due to dysfunction of a single gene. Proc Natl Acad Sci USA 92: 6394-6398, 1995.
199. Rinchik EM and Carpenter DA. N-ethyl-N-nitrosourea mutagenesis of a 6- to 11-cM subregion of the Fah-Hbb interval of mouse chromosome 7: completed testing of 4557 gametes and deletion mapping and complementation analysis of 31 mutations. Genetics 152: 373-383, 1999.
200. Rinchik EM. Developing genetic reagents to facilitate recovery, analysis, and maintenance of mouse mutations. Mamm Genome 11: 489-499, 2000.
201. Ringrose L, Lounnas V, Ehrlich L, Buchholz F, Wade R, and Stewart AF. Comparative kinetic analysis of FLP and Cre recombinases: mathematical models for DNA binding and recombination. J Mol Biol 284: 363-384, 1998.
202. Rodriguez CI, Buchholz F, Galloway J, Sequerra R, Kasper J, Ayala R, Stewart AF, and Dymecki SM. High-efficiency deleter mice show that FLPe is an alternative to Cre-loxP. Nat Genet 25: 139-140, 2000.
203. Rogers DC, Fisher EM, Brown SD, Peters J, Hunter AJ, and Martin JE. Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment. Mamm Genome 8: 711-713, 1997.
204. Ross-Macdonald P, Coelho PS, Roemer T, Agarwal S, Kumar A, Jansen R, Cheung KH, Sheehan A, Symoniatis D, Umansky L, Heidtman M, Nelson FK, Iwasaki H, Hager K, Gerstein M, Miller P, Roeder GS, and Snyder M. Large-scale analysis of the yeast genome by transposon tagging and gene disruption. Nature 402: 413-418, 1999.
205. i2 alpha locus in embryonic stem cells and mice: a modified hit and run strategy with detection by a PCR dependent on gap repair. Transgenic Res 2: 345-355, 1993.
206. Russell WL. X-ray induced mutations in mice. Cold Spring Harbor Symp Quant Biol 16: 327-336, 1951.
207. Russell WL, Kelly PR, Hunsicker PR, Bangham JW, Maddux SC, and Phipps EL. Specific-locus test shows ethylnitrosourea to be the most potent mutagen in the mouse. Proc Natl Acad Sci USA 76: 5918-5922, 1979.
208. Russell LB, Hunsicker PR, Cacheiro NL, Bangham JW, Russell WL, and Shelby MD. Chlorambucil effectively induces deletion mutations in mouse germ cells. Proc Natl Acad Sci USA 86: 3704-3708, 1989.
209. Sakai K and Miyazaki J. A transgenic mouse line that retains Cre recombinase activity in mature oocytes irrespective of the cre transgene transmission. Biochem Biophys Res Commun 237: 318-324, 1997.
210. Salminen M, Meyer BI, and Gruss P. Efficient Poly A trap approach allows the capture of genes specifically active in differentiated embryonic stem cells and in mouse embryos. Dev Dyn 212: 326-333, 1998.
211. Sam M, Wurst W, Kluppel M, Jin O, Heng H, and Bernstein A. Aquarius, a novel gene isolated by gene trapping with an RNA-dependent polymerase motif. Dev Dyn 212: 304-317, 1998.
212. Schimenti J and Bucan M. Functional genomics in the mouse: phenotype-based mutagenesis screens. Genome Res 8: 698-710, 1998.
213. Schmidt EE, Taylor DS, Prigge JR, Barnett S, and Capecchi MR. Illegitimate Cre-dependent chromosome rearrangements in transgenic mouse spermatids. Proc Natl Acad Sci USA 97: 13702-13707, 2000.
214. Schwartzberg PL, Xing L, Hoffmann O, Lowell CA, Garrett L, Boyce BF, and Varmus HE. Rescue of osteoclast function by transgenic expression of kinase-deficient Src in src-/- mutant mice. Genes Dev 11: 2835-2844, 1997.
215. Schwartzberg PL, Goff SP, and Robertson EJ. Germ-line transmission of a c-abl mutation produced by targeted gene disruption in ES cells. Science 246: 799-803, 1989.
216. Scully R and Puget N. BRCA1 and BRCA2 in hereditary breast cancer. Biochimie 84: 95-102, 2002.
217. Shaffer LG and Lupski JR. Molecular mechanisms for constitutional chromosomal rearrangements in humans. Annu Rev Genet 34: 297-329, 2000.
218. Shalaby F, Ho J, Stanford WL, Fischer KD, Schuh AC, Schwartz L, Bernstein A, and Rossant J. A requirement for Flk-1 in primitive and definitive hematopoiesis, and vasculogenesis. Cell 89: 981-990, 1997.
219. Shedlovsky A, Guenet JL, Johnson LL, and Dove WF. Induction of recessive lethal mutations in the T/t-H-2 region of the mouse genome by a point mutagen. Genet Res 47: 135-142, 1986.
220. Shedlovsky A, King TR, and Dove WF. Saturation germ line mutagenesis of the murine t region including a lethal allele at the quaking locus. Proc Natl Acad Sci USA 85: 180-184, 1988.
221. Shin MK, Levorse JM, Ingram RS, and Tilghman SM. The temporal requirement for endothelin receptor-B signalling during neural crest development. Nature 402: 496-501, 1999.
222. Shirai M, Miyashita A, Ishii N, Itoh Y, Satokata I, Watanabe YG, and Kuwano R. A gene trap strategy for identifying the gene expressed in the embryonic nervous system. Zoolog Sci 13: 277-283, 1996.
223. Silver DP and Livingston DM. Self-excising retroviral vectors encoding the Cre recombinase overcome Cre-mediated cellular toxicity. Mol Cell 8: 233-243, 2001.
224. Sims NA, Sabatakos G, Chen JS, Kelz MB, Nestler EJ, and Baron R. Regulating DeltaFosB expression in adult tet-off-DeltaFosB transgenic mice alters bone formation and bone mass. Bone 30: 32-39, 2002.
225. Skarnes WC, Auerbach BA, and Joyner AL. A gene trap approach in mouse embryonic stem cells: the lacZ reported is activated by splicing, reflects endogenous gene expression, and is mutagenic in mice. Genes Dev 6: 903-918, 1992.
226. Skarnes WC, Moss JE, Hurtley SM, and Beddington RS. Capturing genes encoding membrane and secreted proteins important for mouse development. Proc Natl Acad Sci USA 92: 6592-6659, 1995.
227. Smith AJ, De Sousa MA, Kwabi-Addo B, Heppell-Parton A, Impey H, and Rabbitts P. A site-directed chromosomal translocation induced in embryonic stem cells by Cre-loxP recombination. Nat Genet 9: 376-385, 1995.
228. Smith GR, Amundsen SK, Dabert P, and Taylor AF. The initiation and control of homologous recombination in Escherichia coli. Philos Trans R Soc Lond B Biol Sci 347: 13-20, 1995.
229. Smithies O, Gregg RG, Boggs SS, Koralewski MA, and Kucherlapati RS. Insertion of DNA sequences into the human chromosomal β-globin locus by homologous recombination. Nature 317: 230-234, 1985.
230. Soriano P, Gridley T, and Jaenisch R. Retroviruses and insertional mutagenesis in mice: proviral integration at the Mov 34 locus leads to early embryonic death. Genes Dev 1: 366-375, 1987.
231. Stacey A, Schnieke A, McWhir J, Cooper J, Colman A, and Melton DW. Use of double-replacement gene targeting to replace the murine α-lactalbumin gene with its human counterpart in embryonic stem cells and mice. Mol Cell Biol 14: 1009-1016, 1994.
232. Stanford WL, Caruana G, Vallis KA, Inamdar M, Hidaka M, Bautch VL, and Bernstein A. Expression trapping: identification of novel genes expressed in hematopoietic and endothelial lineages by gene trapping in ES cells. Blood 92: 4622-4631, 1998.
233. Stanford WL, Cohn JB, and Cordes SP. Gene-trap mutagenesis: past, present and beyond. Nat Rev Genet 2: 756-768, 2001.
234. Storck T, Kruth U, Kolhekar R, Sprengel R, and Seeburg PH. Rapid construction in yeast of complex targeting vectors for gene manipulation in the mouse. Nucleic Acids Res 24: 4594-6459, 1996.
235. Stoykova A, Chowdhury K, Bonaldo P, Torres M, and Gruss P. Gene trap expression and mutational analysis for genes involved in the development of the mammalian nervous system. Dev Dyn 212: 198-213, 1998.
236. Strausberg RL, Feingold EA, Klausner RD, and Collins FS. The mammalian gene collection. Science 286: 455-457, 1999.
237. Stubbs L, Carver EA, Cacheiro NL, Shelby M, and Generoso W. Generation and characterization of heritable reciprocal translocations in mice. Methods 13: 397-408, 1997.
238. Su H, Wang X, and Bradley A. Nested chromosomal deletions induced with retroviral vectors in mice. Nat Genet 24: 92-95, 2000.
239. Suda Y, Nakabayashi J, Matsuo I, and Aizawa S. Functional equivalency between Otx2 and Otxl in development of the rostral head. Development 126: 743-757, 1999,
240. Sykes PJ, Hooker AM, Harrington CS, Jacobs AK, Kingsbury L, and Morley AA. Induction of somatic intrachromosomal recombination inversion events by cyclophosphamide in a transgenic mouse model. Mutat Res 397: 209-219, 1998.
241. Taniguchi M, Sanbo M, Watanabe S, Naruse I, Mishina M, and Yagi T. Efficient production of Cre-mediated site-directed recombinants through the utilization of the puromycin resistance gene, pac: a transient gene-integration marker for ES cells. Nucleic Acids Res 26: 679-680, 1998.
242. Thomas KR and Capecchi MR. Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell 51: 503-512, 1987.
243. Thomas JW, LaMantia C, and Magnuson T. X-ray-induced mutations in mouse embryonic stem cells. Proc Natl Acad Sci USA 95: 1114-1119, 1998.
244. Thompson S, Clarke AR, Pow AM, Hooper ML, and Melton DW. Germ line transmission and expression of a corrected HPRT gene produced by gene targeting in embryonic stem cells. Cell 56: 313-21, 1989.
245. Threadgill DW, Dlugosz AA, Hansen LA, Tennenbaum T, Lichti U, Yee D, LaMantia C, Mourton T, Herrup K, Harris RC, Barnard JA, Yuspa SH, Coffey RJ, and Magnuson T. Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. Science 269: 230-234, 1995.
246. Townley DJ, Avery BJ, Rosen B, and Skarnes WC. Rapid sequence analysis of gene trap integrations to generate a resource of insertional mutations in mice. Genome Res 7: 293-298, 1997.
247. Tsai TF, Jiang YH, Bressler J, Armstrong D, and Beaudet AL. Paternal deletion from Snrpn to Ube3a in the mouse causes hypotonia, growth retardation and partial lethality and provides evidence for a gene contributing to Prader-Willi syndrome. Hum Mol Genet 8: 1357-1364, 1999.
248. Umana P, Gerdes CA, Stone D, Davis JR, Ward D, Castro MG, and Lowenstein PR. Efficient FLPe recombinase enables scalable production of helper-dependent adenoviral vectors with negligible helper-virus contamination. Nat Biotechnol 19: 582-585, 2001.
249. Urlinger S, Baron U, Thellmann M, Hasan MT, Bujard H, and Hillen W. Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity. Proc Natl Acad Sci USA 97: 7963-7968, 2000.
250. Valancius V and Smithies O. Testing an "in-out" targeting procedure for making subtle genomic modifications in mouse embryonic stem cells. Mol Cell Biol 11: 1402-1408, 1991.
251. Vallis KA, Chen Z, Stanford WL, Hill RP, and Bernstein A. Identification of ionizing radiation-responsive genes: a large-scale, induction gene trap strategy in embryonic stem cells. Radiat Res 157: 8-18, 2002.
252. Van Deursen J, Fornerod M, Van Rees B, and Grosveld G. Cre-mediated site-specific translocation between nonhomologous mouse chromosomes. Proc Natl Acad Sci USA 92: 7376-7380, 1995.
253. Van Etten WJ, Steen RG, Nguyen H, Castle AB, Slonim DK, Ge B, Nusbaum C, Schuler GD, Lander ES, and Hudson TJ. Radiation hybrid map of the mouse genome. Nat Genet 22: 384-387, 1999.
254. Vidan S and Snyder M. Large-scale mutagenesis: yeast genetics in the genome era. Curr Opin Biotechnol 12: 28-34, 2001.
255. Vijaya S, Steffen DL, and Robinson HL. Acceptor sites for retroviral integrations map near DNaseI-hypersensitive sites in chromatin. J Virol 60: 683-692, 1986.
256. Vitaterna MH, King DP, Chang AM, Kornhauser JM, Lowrey PL, McDonald JD, Dove WF, Pinto LH, Turek FW, and Takahashi JS. Mutagenesis and mapping of a mouse gene, Clock, essential for circadian behavior. Science 264: 719-725, 1994.
257. von Melchner H and Ruley HE. Identification of cellular promoters by using a retrovirus promoter trap. J Virol 63: 3227-3233, 1989.
258. Vooijs M, van der Valk M, te Riele H, and Berns A. Flp-mediated tissue-specific inactivation of the retinoblastoma tumor suppressor gene in the mouse. Oncogene 17: 1-12, 1998.
259. Vooijs M, Jonkers J, and Berns A. A highly efficient ligand-regulated Cre recombinase mouse line shows that LoxP recombination is position dependent. EMBO Rep 2: 292-297, 2001.
260. Vos JC, De Baere I, and Plasterk RH. Transposase is the only nematode protein required for in vitro transposition of Tc1. Genes Dev 10: 755-761, 1996.
261. Voss AK, Thomas T, and Gruss P. Efficiency assessment of the gene trap approach. Dev Dyn 212: 171-180, 1998.
262. Wang Y, Krushel LA, and Edelman GM. Targeted DNA recombination in vivo using an adenovirus carrying the cre recombinase gene. Proc Natl Acad Sci USA 93: 3932-3936, 1996.
263. Wang Y, DeMayo FJ, Tsai SY, and O'Malley BW. Ligand-inducible and liver-specific target gene expression in transgenic mice. Nat Biotechnol 15: 239-243, 1997.
264. Wang XJ, Liefer KM, Tsai S, O'Malley BW, and Roop DR. Development of gene-switch transgenic mice that inducibly express transforming growth factor 1 in the epidermis. Proc Natl Acad Sci USA 96: 8483-8488, 1999.
265. Wattler S, Kelly M, and Nehls M. Construction of gene targeting vectors from lambda KOS genomic libraries. Biotechniques 26: 1150-1156, 1999.
266. Weber F, de Villiers J, and Schaffner W. An SV40 "enhancer trap" incorporates exogenous enhancers or generates enhancers from its own sequences. Cell 36: 983-992, 1984.
267. Weiss MJ, Keller G, and Orkin SH. Novel insights into erythroid development revealed through in vitro differentiation of GATA-1-embryonic stem cells. Genes Dev 8: 1184-1197, 1994.
268. Westerman KA and Leboulch P. Reversible immortalization of mammalian cells mediated by retroviral transfer and sitespecific recombination. Proc Natl Acad Sci USA 93: 8971-8976, 1996.
269. Whyatt LM and Rathjen PD. Introduction of precise alterations into the mouse genome with high efficiency by stable tag-exchange gene targeting: implications for gene targeting in ES cells. Nucleic Acids Res 25: 2381-2388, 1997.
270. Wiles MV, Vauti F, Otte J, Fuchtbauer EM, Ruiz P, Fuchtbauer A, Arnold HH, Lehrach H, Metz T, von Melchner H, and Wurst W. Establishment of a gene-trap sequence tag library to generate mutant mice from embryonic stem cells. Nat Genet 24: 13-14, 2000.
271. Wilson C, Pearson RK, Bellen HJ, O'Kane CJ, Grossniklaus U, and Gehring WJ. P-element-mediated enhancer detection: an efficient method for isolating and characterizing developmentally regulated genes in Drosophila. Genes Dev 3: 1301-1313, 1989.
272. Wu H, Liu X, and Jaenisch R. Double replacement: strategy for efficient introduction of subtle mutations into the murine Col1a-1 gene by homologous recombination in embryonic stem cells. Proc Natl Acad Sci USA 91: 2819-2823, 1994.
273. Wurst W, Rossant J, Prideaux V, Kownacka M, Joyner A, Hill DP, Guillemot F, Gasca S, Cado D, and Auerbach A. A large-scale gene-trap screen for insertional mutations in developmentally regulated genes in mice. Genetics 139: 889-899, 1995.
274. Wurst W and Gossler A. Gene trap strategies in ES cells. In: Gene Targeting: A Practical Approach (2nd ed.), edited by Joyner AL. New York: Oxford University Press, 2000, chapt. 6, p. 207-254.
275. Yang W, Musci TS, and Mansour SL. Trapping genes expressed in the developing mouse inner ear. Hear Res 114: 53-61, 1997.
276. Yant SR, Meuse L, Chiu W, Ivics Z, Izsvak Z, and Kay MA. Somatic integration and long-term transgene expression in normal and haemophilic mice using a DNA transposon system. Nat Genet 25: 35-41, 2000.
277. Yergeau DA, Hetherington CJ, Wang Q, Zhang P, Sharpe AH, Binder M, Marin-Padilla M, Tenen DG, Speck NA, and Zhang DE. Embryonic lethality and impairment of haematopoiesis in mice heterozygous for an AML1-ETO fusion gene. Nat Genet 15: 303-306, 1997.
278. Yokoyama T, Silversides DW, Waymire KG, Kwon BS, Takeuchi T, and Overbeek PA. Conserved cysteine to serine mutation in tyrosinase is responsible for the classical albino mutation in laboratory mice. Nucleic Acids Res 18: 7293-7298, 1990.
279. You Y, Bergstrom R, Klemm M, Lederman B, Nelson H, Ticknor C, Jaenisch R, and Schimenti J. Chromosomal deletion complexes in mice by radiation of embryonic stem cells. Nat Genet 15: 285-288, 1997.
280. Yu D, Ellis HM, Lee EC, Jenkins NA, Copeland NG, and Court DL. An efficient recombination system for chromosome engineering in Escherichia coli. Proc Natl Acad Sci USA 97: 5978-5983, 2000.
281. Yu Y and Bradley A. Mouse genomic technologies: engineering chromosomal rearrangements in mice. Nat Rev Genet 2: 780-790, 2001.
282. Zambrowicz BP, Friedrich GA, Buxton EC, Lilleberg SL, Person C, and Sands AT. Disruption and sequence identification of 2,000 genes in mouse embryonic stem cells. Nature 392: 608-611, 1998.
283. Zhang Y, Buchholz F, Muyrers JP, and Stewart AF. A new logic for DNA engineering using recombination in Escherichia coli. Nat Genet 20: 123-128, 1998.
284. Zhang Y, Muyrers JP, Testa G, and Stewart AF. DNA cloning by homologous recombination in Escherichia coli. Nat Biotechnol 18: 1314-1317, 2000.
285. Zhang P, Li MZ, and Elledge SJ. Towards genetic genome projects: genomic library screening and gene-targeting vector construction in a single step. Nat Genet 30: 31-39, 2002.
286. Zhao S, Shatsman S, Ayodeji B, Geer K, Tsegaye G, Krol M, Gebregeorgis E, Shvartsbeyn A, Russell D, Overton L, Jiang L, Dimitrov G, Tran K, Shetty J, Malek JA, Feldblyum T, Nierman WC, and Fraser CM. Mouse BAC ends quality assessment and sequence analyses. Genome Res 11: 1736-1745, 2001.
287. Zheng B, Sage M, Cai WW, Thompson DM, Tavsanli BC, Cheah YC, and Bradley A. Engineering a mouse balancer chromosome. Nat Genet 22: 375-378, 1999.
288. Zheng B, Mills AA, and Bradley A. A system for rapid generation of coat color-tagged knockouts and defined chromosomal rearrangements in mice. Nucleic Acids Res 27: 2354-2360, 1999.
289. Zheng B, Sage M, Sheppeard EA, Jurecic V, and Bradley A. Engineering mouse chromosomes with Cre-loxP: range, efficiency, and somatic applications. Mol Cell Biol 20: 648-655, 2000.
290. Zheng B, Mills AA, and Bradley A. Introducing defined chromosomal rearrangements into the mouse genome. Methods 24: 81-94, 2001.